Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
351
Views
11
CrossRef citations to date
0
Altmetric
Original Research

The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database

Zhenyu Pan1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China;2 School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China;3 Department of Pharmacy, Xi’an Children’s Hospital, Xi’an, Shaanxi, People’s Republic of China
,
Jun Zhang1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China;2 School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China;4 Department of Orthopaedics, Baoji Municipal Central Hospital, Baoji, Shaanxi, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1263-1195
ORCID Icon,
Qingting Bu5 Department of Genetics, Northwest Women’s and Children’s Hospital, Xi’an, Shaanxi, People’s Republic of China
,
Hairong He1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Ling Bai1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Jin Yang1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China;2 School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China
,
Qingqing Liu1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China;2 School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China
&
Jun Lyu1 Clinical Research Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China;2 School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China;6 Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2237-8771
ORCID Icon show all
Pages 1281-1286 | Published online: 04 May 2020

References

  • Hershkovitz I, Donoghue HD, Minnikin DE, et al. Tuberculosis origin: the neolithic scenario. Tuberculosis. 2015;95(Suppl 1):S122–S126. doi:10.1016/j.tube.2015.02.02125726364
  • Churchyard G, Kim P, Shah NS, et al. What we know about tuberculosis transmission: an overview. J Infect Dis. 2017;216(suppl_6):S629–s635. doi:10.1093/infdis/jix36229112747
  • Gong W, Liang Y, Wu X. The current status, challenges, and future developments of new tuberculosis vaccines. Hum Vaccin Immunother. 2018;14(7):1697–1716. doi:10.1080/21645515.2018.145880629601253
  • Gebremichael B, Abebaw TA, Moges T, Abaerei AA, Worede N. Predictors of pediatric tuberculosis in public health facilities of Bale Zone, Oromia region, Ethiopia: a case control study. BMC Infect Dis. 2018;18(1):252. doi:10.1186/s12879-018-3163-029866076
  • Global tuberculosis report 2018. Available from: https://www.who.int/tb/publications/global_report/en/. Accessed 38, 2019.
  • The end TB strategy; 2014 Available from: https://www.who.int/tb/strategy/End_TB_Strategy.pdf?ua=1. Accessed 121,2019.
  • Global tuberculosis report 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1. Accessed 121, 2019.
  • Lonnroth K, Raviglione M. The who’s new end TB strategy in the post-2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg. 2016;110(3):148–150. doi:10.1093/trstmh/trv10826884490
  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858.30496104
  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349(9064):1498–1504. doi:10.1016/S0140-6736(96)07492-29167458
  • Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the global burden of disease study. Lancet. 2017;390(10100):1460–1464. doi:10.1016/S0140-6736(17)32367-X28919120
  • Global Burden of Disease Collaborative Network. Global burden of disease study 2017 (GBD 2017) results. institute for health metrics and evaluation (IHME); 2018 Available from: http://ghdx.healthdata.org/gbd-results-tool. Accessed 418, 2020.
  • GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151–1210. doi:10.1016/S0140-6736(17)32152-928919116
  • National Tuberculosis Institute. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Heal Organ. 1974;51(5):473–488.
  • Szkwarko D, Bouton TC, Rybak NR, Carter EJ, Chiang SS. Tuberculosis: an epidemic perpetuated by health inequalities. Rhode Island Med j. 2019;102(7):47–50.
  • Tichenor M, Sridhar D. Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation. Wellcome Open Res. 2019;4:35. doi:10.12688/wellcomeopenres.15011.130863794
  • Methods used by WHO to estimate the global burden of TB disease. 2019 Available from: https://www.who.int/tb/publications/global_report/tb19_technical_appendix.pdf?ua=1. Accessed 121.
  • Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. Lancet Res Med. 2018;6(4):299–314. doi:10.1016/S2213-2600(18)30057-2
  • GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18(3):261–284. doi:10.1016/S1473-3099(17)30703-X29223583
  • GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990–2016: results from the global burden of diseases, injuries, and risk factors 2016 study. Lancet Infect Dis. 2018;18(12):1329–1349. doi:10.1016/S1473-3099(18)30625-X30507459
  • Gomes MG, Barreto ML, Glaziou P, et al. End TB strategy: the need to reduce risk inequalities. BMC Infect Dis. 2016;16:132. doi:10.1186/s12879-016-1464-827001766
  • Ogbo FA, Ogeleka P, Okoro A, et al. Tuberculosis disease burden and attributable risk factors in Nigeria, 1990–2016. Trop Med Health. 2018;46:34. doi:10.1186/s41182-018-0114-930262990
  • Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet. 2015;385(9979):1799–1801. doi:10.1016/S0140-6736(15)60570-025814376

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.